Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.

The UK government has set out the scope and ambition for their new Cyber Security and Resilience Bill (CSRB), which aims to ...

Samsung has launched its mid-range smartphone Galaxy A36 5G, earlier this month. The primary highlight of the smartphone is ...

Compass Therapeutics' Phase 2/3 trial shows tovecimig plus paclitaxel significantly improves response rates in advanced biliary tract cancer patients.

A significant spike in scanning activity targeting Palo Alto Network GlobalProtect login portals has been observed, with ...

World Outcomes Of Non-Small Cell Lung Cancer Patients Harbouring Kras G12c And Kras G12d Mutations," published in the March ...

Geovation, an initiative from Ordnance Survey which supports startups in solving industry challenges, has launched a new scheme in partnership with the UK government.

Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one complete response, compared to 5.3% ORR for paclitaxel alone, ...

The Open Space Institute (OSI) and Lumbee Tribe of North Carolina have announced the acquisition of the 1,382-acre Camp Island property near North Carolina’s southeastern ...

OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

Ordnance Survey provides new data on 40 million roofs, revealing which properties are most suitable for solar installations ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...